Skip to content
Live From WCLC 2025: Monday Highlights episode artwork

Sep 8, 2025 42 min

Live From WCLC 2025: Monday Highlights

from Lung Cancer Considered Hosted by IASLC

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase III trial. Dr. Jacie Jiaqi Law shares survival outcomes of VATS compared to open lobectomy, and Dr. Corinne Faivre-Finn and Dr. Shankar Siva summarize results from the EA5181 trial of concurrent and consolidation durvalumab after chemoradiation for unresectable NSCLC and hypofractionation vs conventional fractionation for LS SCLC.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Live From WCLC 2025: Monday Highlights

0:00 42:29

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 42 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on September 8, 2025.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.